SIMONATO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 11.202
EU - Europa 4.672
AS - Asia 2.171
SA - Sud America 22
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.074
Nazione #
US - Stati Uniti d'America 11.182
PL - Polonia 1.893
CN - Cina 1.088
UA - Ucraina 602
SG - Singapore 575
IT - Italia 568
DE - Germania 415
TR - Turchia 357
RU - Federazione Russa 343
GB - Regno Unito 315
FI - Finlandia 219
SE - Svezia 124
ID - Indonesia 66
CZ - Repubblica Ceca 51
FR - Francia 46
VN - Vietnam 31
AT - Austria 27
BE - Belgio 25
CA - Canada 17
LT - Lituania 14
IR - Iran 13
CO - Colombia 12
IN - India 11
HK - Hong Kong 9
BR - Brasile 8
NL - Olanda 8
KR - Corea 6
ES - Italia 4
IE - Irlanda 4
PT - Portogallo 4
AU - Australia 3
CH - Svizzera 3
PK - Pakistan 3
DK - Danimarca 2
EU - Europa 2
JP - Giappone 2
MX - Messico 2
MY - Malesia 2
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KW - Kuwait 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 18.074
Città #
Warsaw 1.892
Fairfield 1.546
Woodbridge 1.533
Houston 856
Ashburn 822
Jacksonville 719
Chandler 675
Ann Arbor 607
Seattle 603
Santa Clara 569
Wilmington 539
Cambridge 502
Singapore 479
Beijing 254
Nanjing 231
Izmir 229
Ferrara 195
Princeton 169
San Diego 147
Shanghai 95
New York 92
Boardman 88
Helsinki 85
Milan 83
Jakarta 65
Los Angeles 65
Nanchang 64
Shenyang 56
Jiaxing 49
Washington 49
Dearborn 42
Brno 41
Changsha 35
Bremen 33
Hebei 33
Munich 32
London 31
Norwalk 31
Dong Ket 30
Tianjin 30
Kunming 29
Vienna 27
Redwood City 26
Brussels 24
Mountain View 24
Jinan 23
San Mateo 23
Auburn Hills 22
Ningbo 22
Falkenstein 18
Falls Church 18
Zhengzhou 18
Bologna 16
Des Moines 16
Verona 16
Rome 14
Bogotá 12
Toronto 12
Frankfurt am Main 11
Philadelphia 11
Augusta 10
Guangzhou 10
Tappahannock 10
Hangzhou 9
Hong Kong 9
Orange 9
Phoenix 9
Kilburn 8
Olomouc 8
Redmond 8
Taizhou 8
Changchun 7
Düsseldorf 7
Lanzhou 7
Lappeenranta 7
Leawood 7
Addison 6
Ardabil 6
Haikou 5
Monmouth Junction 5
Pisa 5
Arezzo 4
Chicago 4
Dublin 4
Hefei 4
Hounslow 4
Islington 4
Candia Lomellina 3
Chiswick 3
Como 3
Indiana 3
Leipzig 3
Orciano di Pesaro 3
Paris 3
Perugia 3
Pieve Emanuele 3
Serpa 3
Turin 3
Vicenza 3
Wandsworth 3
Totale 14.301
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 452
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 318
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 298
Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus 292
WONOEP appraisal: New genetic approaches to study epilepsy 283
Meta-analysis of microRNAs dysregulated in the hippocampal dentate gyrus of animal models of epilepsy 279
Progress in gene therapy for neurological disorders 274
Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs 274
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 273
Harmonization in preclinical epilepsy research: A joint AES/ILAE translational initiative 273
The challenge and promise of anti-epileptic therapy development in animal models 271
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 268
Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-€“A TASK2 report of the AES/ILAE Translational Task Force of the ILAE 252
Engineered HSV vector achieves safe long-term transgene expression in the central nervous system 150
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 147
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 144
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 143
Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study 143
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 143
A pathogenetic hypothesis of temporal lobe epilepsy 142
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 134
Loss of cortical GABA terminals in Unverricht–Lundborg disease 134
Angels and demons: neurotrophic factors and epilepsy 133
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 133
Personalized needles for microinjections in the rodent brain 132
Characterization of K+-evoked [3H]d-aspartate outflow in the rat hippocampus in vitro 131
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors 131
Advances in the development of biomarkers for epilepsy 130
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 129
GABAA-Current Run-down of Temporal Lobe Epilepsy is Associated with Repetitive Activation of GABAA "Phasic" Receptors 128
Characterization of glutamate and [3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. 127
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives 126
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 126
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 124
The neurochemistry of morphine addiction in the neocortex. 124
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 124
Silencing status epilepticus-induced BDNF expression with herpes simplex virus type-1 based amplicon vectors 124
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. 124
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 123
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 123
null 123
Effect of arachidonic acid on [3H]d-aspartate outflow in the rat hippocampus 122
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 122
Antinociceptive activity of the N-Methyl-D- Aspartate Receptor Antagonist N-(2-indanyl)-glycinamide hydrochloride CHF3381 in Experimental Models of Inflammatory and Neuropathic Pain 119
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 119
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 119
Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat. 118
Induction of B1 bradykinin receptors in the kindled brain. 117
Changes in NPY-mediated modulation of hippocampal [H-3]D-aspartate outflow in the kindling model of epilepsy 117
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 117
Induction of B-1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels: A microdialysis study 117
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 117
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology 117
Dose- and time-dependent hippocampal cholinergic lesions induced by ethylcholine mustard aziridinium ion: effects of nerve growth factor, GM1 ganglioside and vitamin E 116
Fisiologia e fisiopatologia di BDNF: verso lo sviluppo di nuove strategie terapeutiche per alcune delle principali malattie neuro-psichiatriche 115
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 115
Mechanisms of action of CHF3381 in the forebrain 114
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 114
Biotin-deficiency facilitates kindling hyperexcitability in rats. 113
Common data elements and data management: Remedy to cure underpowered preclinical studies 112
Fibroblast Growth Factor-2 (FGF-2). 111
null 111
Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy 110
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 110
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 108
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 108
Evaluation of cell damage in organotypic hippocampal slice culture from adult mouse: a potential model system to study neuroprotection 107
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine 107
WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients? 107
Opportunities for improving animal welfare in rodent models of epilepsy and seizures 107
Gene Therapy Tools for Brain Diseases 107
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design 106
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 106
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 106
Targeting kinin receptors for the treatment of neurological diseases 105
BODIPY (R)-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes 105
Identification of new epilepsy treatments for: issues in preclinical methodology 103
Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy 103
Cell Therapy for Epilepsy 102
Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development 101
Finding a better drug for epilepsy: Antiepileptogenesis targets 101
Long-term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy 100
Opioid peptides and seizures. 99
Circadian differences in the individual sensitivity to opiate overdose 99
What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development. 99
On the role of somatostatin in seizure control: Clues from the hippocampus 99
Kindled seizure-induced c-fos and prodynorphin mRNA expressions are unrelated in the rat brain. 98
Time- and region-specific variations in somatostatin release following amygdala kindling in the rat 98
null 97
Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. 96
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 96
null 95
Unverricht-Lundborg disease 95
null 94
null 94
Region-specific changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures. 94
New tools for epilepsy therapy 94
null 94
null 93
null 93
Totale 13.780
Categoria #
all - tutte 78.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.743
Totale 81.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.309 0 0 0 0 0 438 382 391 327 431 218 122
2020/20212.528 203 254 132 247 140 242 138 283 111 353 281 144
2021/20221.730 58 233 132 51 37 57 99 114 74 116 185 574
2022/20231.607 192 68 104 160 247 221 66 180 205 12 99 53
2023/20241.348 96 109 63 24 94 278 111 142 77 81 64 209
2024/20251.642 133 115 337 174 450 433 0 0 0 0 0 0
Totale 18.341